An interventional study of Fitness app for self-efficacy and Social network via app for social support in Older Adults With Cognitive Decline, Older Adults and AI-Based Fitness, sponsored by The University of Tennessee, Knoxville. Recruiting at 2 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by The University of Tennessee, Knoxville · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,423 studies in Cognitive Dysfunction with a site in United States — 330 open to participants now, 432 under way, 13 of them phase 3. Cognitive Dysfunction · United States.
Among the 1,423 studies in Cognitive Dysfunction with a site in United States, this one is the 518th largest by planned enrollment of the 1,147 interventional ones that give a count, is one of 97 that started in 2026, is one of 716 with no phase, reaches primary completion later than 329 of the 431 other live ones, and was the 1,317th registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →330 of the 1,423 studies in Cognitive Dysfunction with a site in United States are open now. Recruiting first, the newest first:
National Institute of Mental Health (NIMH) · Sites in United States
Ages 50–100 · Healthy volunteers
Prevention Research Consortium Corp. · Sites in United States
Ages 55+ · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 65+
University of Pittsburgh · Sites in United States
Ages 65+
The University of Texas Medical Branch, Galveston · Sites in United States
Ages 50–100 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,423 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 126 · Phase 2 234 · Phase 3 54 · Phase 4 58
First in 1993; this study’s year is marked. 97 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 64 is close to the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 59 across the 1,147 interventional studies, 150 across the 271 observational. Of the 890 that completed or were terminated, 379 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
209 of 1,423 have an industry lead sponsor. The 10 most frequent:
The University of Tennessee, Knoxville is the lead sponsor of 95 studies on the registry; 5 are open to participants now.
The University of Tennessee, Knoxville has 1 study filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
173 of the studies in Cognitive Dysfunction with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03860857Phase 3University of California, IrvineBiomarker Exploration in Aging, Cognition and Neurodegeneration | 2026-12-22 |
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT06191965Phase 3Mclean HospitalMitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction | 2027-01-31 |
| NCT06950190Phase 3Ellis MedicineEvaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) | 2027-02-20 |
| NCT03560960Boston UniversityMulti-Center Development of a Novel Diagnostic Test for Alzheimer's Disease | 2026-11 |
Add all 173 to your calendar (.ics) → With an account.
Among the 1,423 studies in Cognitive Dysfunction with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) and improving health among community-dwelling older adults living alone with cognitive decline (LACD). To achieve this goal, the purpose of this project is to determine whether wearable and app-based mHealth intervention component(s) will contribute to increased PA and improved health outcomes in older adults LACD. Our specific aims are to: identify and evaluate mHealth intervention components that practically and significantly contribute to enhanced mechanistic outcomes (e.g., self-efficacy, outcome expectations) and increased PA (primary outcome) in older adults LACD over a 6-month period; determine the optimal combinations of intervention components for future efficacy testing; elucidate the mechanism of behavioral change (MoBC) and potential outcomes of these intervention components, namely, the mediating effects of MoBC variables (e.g., self-efficacy, outcome expectations) on the relationship between intervention components and change in PA. The first two aims are primary and fully-powered. The third aim is exploratory. The aims will support a refined, data-driven intervention design for a subsequent larger trial.
Mobile health (mHealth) is a promising approach to improving health behaviors, defined as "health services and information delivered or enhanced through the Internet and related technologies." It includes disease prevention and management tools, remote interventions, personalized health monitoring, and mobile healthcare data access. With widespread technology adoption, researchers increasingly use wearable devices and apps to enhance health outcomes by promoting PA and reducing sedentary behavior. Wearable devices and fitness apps are now widely integrated into PA intervention programs, helping individuals adopt more active lifestyles. These tools track steps, activity duration, and progress, providing real-time feedback, goal-setting, and social integration to enhance motivation and behavior regulation. Notably, 21% of U.S. adults regularly use smartwatches or fitness trackers, making them feasible for PA interventions in older adults. RCTs have shown their positive effects on PA, QoL, and psychosocial well-being in older adults though some studies reported modest improvements. Recent advancements in data science and AI-driven mHealth interventions enable scalable, personalized exercise prescriptions. Personalized approaches, particularly those enhancing self-efficacy, yield better outcomes than generalized interventions. However, few studies have leveraged fitness wearables and apps for older adult LACD. This trial addresses this major weakness by implementing an AI-driven mHealth intervention for tailored precision health programs in older adult LACD.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Condition 1: Participant are provided with the prescription application (application1), social application (application 2), and health tips application (application 3).
Other: Fitness app for self-efficacy · Other: Social network via app for social support · Other: Health education app targeting outcome expectations
Condition 2: Participant are provided with the prescription application, social application, but they aren't provided with the health tips application.
Other: Fitness app for self-efficacy · Other: Social network via app for social support
Condition 3: Participant are provided with the prescription application, and they aren't provided with the social application, but they are provided with the health tips application.
Other: Fitness app for self-efficacy · Other: Health education app targeting outcome expectations
Condition 4: Participant are provided with the prescription application, but aren't provided with the social application, and the health tips application.
Other: Fitness app for self-efficacy
Condition 5: Participant are not provided with the prescription application, but they are provided with the social application, and the health tips application.
Other: Social network via app for social support · Other: Health education app targeting outcome expectations
Condition 6: Participant are not provided with the prescription application, but they are provided with the social application, and they aren't provided with the health tips application.
Other: Social network via app for social support
Condition 7: Participant are not provided with the prescription application, or the social application, but they are provided with the health tips application.
Other: Health education app targeting outcome expectations
Condition 8: Participant are not provided with the prescription application, or the social application, or with the health tips application.
AI-driven personalized exercise prescription via a fitness app. This targets self-efficacy.
Participants will be provided access to a social network via app. This targets social support.
Participants are provided with an app-based health education. This targets outcome expectations.
Fitbit MVPA
Fitbit Inspire 3 Tracker will be used to assess participants' MVPA (active time which includes both fairly active time and very active time). Fairly active; duration associated with light intensity activities, i.e., walking, light cycling, housework (\~3-6 METs). Very active; duration associated with high intensity activities, i.e., running, aerobic workouts (\>6 METs).
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Physical Activity
We will use the Physical Activity Scale for the Elderly to assess PA. Higher scores means more physical activity. (Low activity: \<100; Moderate: 100-250; High: \>250)
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Mechanism of behavior change (MoBC) variables
Psychometrically validated questionnaires will be used to assess beliefs: self-efficacy, social support, and outcome expectations. Self-efficacy; low score indicates low confidence in ability to perform behavior, high score indicates strong confidence. Social support; low score indicates poor support from family or friends, high score indicates great support. Outcome expectation; low score indicates the belief that behavior won't help, high score indicates the belief that the behavior will lead to positive outcome.
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Quality of life (QoL)
We will select the brief Older People's Quality of Life questionnaire to assess quality of life (OPQOL-BRIEF). Minimum: 13 (very poor quality of life) Maximum: 65 (excellent quality of life)
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Psychosocial wellbeing
We will assess wellbeing using the World Health Organization Well-Being Index (WHO-5) questionnaire. 0 -12 - Low well-being; possible depression (screen positive) 13 - 19 - Moderate well-being 20 - 25 - High well-being
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Cognition
To assess older adults' cognition (thinking and memory), we will use the 5-minute Montreal Cognitive Assessment (MoCA). 26 - 30: Normal; Indicates health cognitive functioning for most adults. 18 - 25: Mild Cognitive Impairment (MCI); Shows noticeable memory or thinking issues that do not severely disrupts daily life. 10 - 17: Moderate Cognitive Impairment; Suggests a heightened progression towards early-to-mid stage dementia. Less than 10: Severe Cognitive Impairment.
Time frame: Baseline (i.e., pre-intervention), 3 months (mid-point), and 6 months (end-point).
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Jun 2028, 24 months after the start.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 24 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Tennessee, Knoxville